Armistice Capital’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-214,947
Closed -$1.82M 379
2025
Q2
$1.82M Sell
214,947
-21,667
-9% -$221K 0.03% 137
2025
Q1
$2.67M Sell
236,614
-67,754
-22% -$1.23M 0.04% 136
2024
Q4
$6.21M Sell
304,368
-53,785
-15% -$1.57M 0.08% 118
2024
Q3
$14.2M Buy
358,153
+35,989
+11% +$968K 0.23% 82
2024
Q2
$5.67M Buy
322,164
+59,200
+23% +$1M 0.07% 110
2024
Q1
$4.37M Buy
262,964
+77,764
+42% +$1.13M 0.06% 127
2023
Q4
$3.5M Sell
185,200
-96,500
-34% -$1.81M 0.05% 136
2023
Q3
$5.86M Buy
281,700
+243,200
+632% +$7.39M 0.09% 109
2023
Q2
$2.1M Buy
38,500
+2,100
+6% +$64.6K 0.03% 145
2023
Q1
$659K Sell
36,400
-84,608
-70% -$1.46M 0.01% 151
2022
Q4
$1.23M Buy
121,008
+25,108
+26% +$269K 0.02% 125
2022
Q3
$1.27M Buy
95,900
+75,249
+364% +$1.14M 0.02% 134
2022
Q2
$266K Buy
+20,651
New +$546K ﹤0.01% 150

Other funds holding RMTI

Armistice Capital's RMTI Position: Q3 2025 in Review

Armistice Capital sold out of Rockwell Medical (RMTI) in Q3 2025, closing a stake of 214,947 shares — an estimated $1.82M sold.

Armistice Capital first reported a position in RMTI in Q2 2022 and held it in 13 quarters. The position peaked at $14.2M in Q3 2024. 36 funds tracked by Wall St. Rank hold RMTI as of Q3 2025.

  • Armistice Capital reported no remaining Rockwell Medical position as of Q3 2025 after selling out during the quarter.
  • Armistice Capital sold 214,947 Rockwell Medical shares in Q3 2025, an estimated $1.82M.
  • Armistice Capital first reported a position in Rockwell Medical in Q2 2022 and held it in 13 quarters.
  • Armistice Capital's Rockwell Medical position peaked at $14.2M in Q3 2024.
  • 36 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2025.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.